Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
402.5 USD | +0.35% | +1.59% | -1.08% |
12:31pm | Leerink Partners Adjusts Vertex Pharmaceuticals' Price Target to $529 From $511 | MT |
12:30pm | Stifel Adjusts Vertex Pharmaceuticals' Price Target to $420 From $430 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.08% | 104B | |
+9.15% | 106B | |
+6.87% | 23.25B | |
-11.55% | 22.5B | |
-7.19% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B | |
+320.26% | 8.62B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Barclays Adjusts Price Target on Vertex Pharmaceuticals to $472 From $446, Keeps Overweight Rating